A coalition of a dozen Democratic attorneys general sued the Food and Drug Administration on Friday to force the agency to drop all remaining restrictions on the abortion pill. It adds to an ...
A group of Democratic state attorneys general have filed a lawsuit against the Food and Drug Administration (FDA), accusing the ... and is burdensome due to the restrictions it places on who ...
Wade, the FDA is now exposing doctors, pharmacists and patients to unnecessary risk. The FDA’s excessive restrictions on this important drug have no basis in medical science.” In 2000, the FDA ...
While the Washington case primarily asks the court to order the FDA to eliminate a framework of extra restrictions applied to mifepristone, the suit also asks the judge to declare that the FDA's ...
(Read the lawsuit below.) Only 60 FDA-approved drugs, out of some 20,000, fall under the restrictions known as Risk Evaluation & Mitigation Strategies, or REMS, according to a statement from Raoul ...
Details: The FDA approved mifepristone more than two decades ago under the agency's Risk Evaluation and Mitigation Strategy, a program that adds dispensing restrictions to certain drugs ...
Leaders of North Carolina's Republican-controlled legislature have intervened to defend the state's restriction on the abortion pill mifepristone. Dr. Amy Bryant, a North Carolina physician, sued ...
Airline traffic is recovering quickly from coronavirus restrictions that led to jets being grounded worldwide in 2020, with manufacturers now struggling to keep pace with aircraft demand and ...
Los Angeles County pandemic health orders are being phased out to align with state rules. In a Friday press conference, county Public Health Director Barbara Ferrer told reporters that COVID-19 ...
Starting Monday, May 24, gymnasiums and duty-free shops, which have been closed since March 23 as part of the restrictions against the rise in covid-19 infections, may reopen, under strict ...
“FDA’s decision to continue these burdensome restrictions in January 2023 on a drug that has been on the market for more than two decades with only ‘exceedingly rare’ adverse events has no ...
